300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
South Africa
Canada
Ireland
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Angel Investors in Europe (September 2026)

The most active angel investors investing in Europe Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Europe Life Science startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Jonathan Milner
Angel
11 United Kingdom, United States, Spain Seed, Series A, Series B Biotechnology, Health Care, Medical $537k–$56M
Nadav Rosenberg
Angel
5 United Kingdom, France, Israel Seed, Pre-Seed, Series A Software, Biotechnology, Artificial Intelligence $1.1M–$21M
Stefano Bernardi
Angel
3 Italy, United Kingdom, Canada Seed, Pre-Seed Blockchain, Software, Biotechnology $100k–$18M
Jeff Dean
Angel
3 United States, United Kingdom, Japan Seed, Series A, Pre-Seed Artificial Intelligence, Information Technology, Software $450k–$60M
Annie Vereecken
Angel
3 Belgium Seed, Series A, Venture - Series Unknown Medical, Biotechnology, Hospital $2M–$30M
Andrew Keys
Angel
3 United States, India, Norway Seed, Pre-Seed, Series A Software, Finance, Blockchain $1M–$34M
Jude Gomila
Angel
3 United States, United Kingdom, India Seed, Pre-Seed, Angel Software, Information Technology, Artificial Intelligence $70k–$5M
David Helgason
Angel
2 United States, Denmark, Finland Seed, Series A, Pre-Seed Software, Gaming, Artificial Intelligence $242k–$30M
Ian Hogarth
Angel
2 United Kingdom, United States, Germany Seed, Pre-Seed, Series A Software, Artificial Intelligence, SaaS $698k–$43M
Ersin Pamuksüzer
Angel
2 Turkey, Germany Seed, Series A Education, Life Science, Virtual Reality $300k–$500k
Mark Evans
Angel
2 United Kingdom, United States, The Netherlands Series A, Seed, Series C Retail, Fashion, Software $1.4M–$68M
Sauli Törmälä
Angel
2 Finland Seed Life Science, Biotechnology $598k–$1.3M
Sylvain Zimmer
Angel
2 France, United States, United Kingdom Seed, Pre-Seed, Angel Software, SaaS, Real Estate $200k–$10M
Andrew Nutter
Angel
2 France, United Kingdom, United States Seed, Pre-Seed, Venture - Series Unknown Software, SaaS, FinTech $550k–$4.9M
Paul Wicks
Angel
2 United Kingdom, United States, Japan Seed, Pre-Seed, Series A Software, Wellness, E-Commerce $539k–$11M
Dr Guntard Gutmann
Angel
2 Germany Convertible Note, Venture - Series Unknown Health Care, Life Science, Therapeutics
Albert Wenger
Angel
2 United States, Germany, Switzerland Series A, Series B, Seed Software, Internet, Analytics $650k–$30M
Nicholas Edwards
Angel
2 United Kingdom Seed, Venture - Series Unknown Medical, Health Care, Life Science
Leena Niemistö
Angel
2 Finland, United States Seed, Venture - Series Unknown, Pre-Seed Health Care, Software, E-Commerce $306k–$3.5M
Nico Wittenborn
Angel
2 United States, Germany, France Seed, Series A, Series B Software, Apps, Wellness $1.6M–$88M
Matt Clifford
Angel
2 United Kingdom, United States, India Seed, Pre-Seed, Venture - Series Unknown Software, Artificial Intelligence, FinTech $55k–$34M
Carsten Maschmeyer
Angel
2 Germany, Austria, Switzerland Seed, Angel, Series A Software, Artificial Intelligence, Information Technology $89k–$24M
Balaji Srinivasan
Angel
2 United States, India, Singapore Seed, Pre-Seed, Series A Blockchain, Cryptocurrency, Software $650k–$28M
Michael Novogratz
Angel
2 United States, India, Germany Seed, Series A, Series B Blockchain, Cryptocurrency, FinTech $1.1M–$150M
Holger Hübner
Angel
2 Germany Seed, Pre-Seed B2B, SaaS, Audio $177k–$1.1M
Robert Kopple
Angel
2 United States, United Kingdom Convertible Note, Venture - Series Unknown FinTech, Finance, Life Science $3.3M–$4.8M
Mati Staniszewski
Angel
2 United States, United Kingdom, Poland Seed, Pre-Seed, Series A Artificial Intelligence, Software, SaaS $2M–$75M
Simon Galbraith
Angel
2 Croatia, United Kingdom Seed, Pre-Seed, Venture - Series Unknown Software, Health Care, Life Science
Luc Vauterin
Angel
2 Belgium Seed, Series A Software, Analytics, Life Science
Bradley Horowitz
Angel
2 United States, United Kingdom, Germany Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $150k–$120M
Edward Lando
Angel
2 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, FinTech, Artificial Intelligence $125k–$37M
Pierre Drion
Angel
2 Belgium Series A, Series B Biotechnology, Health Care, Life Science $8.8M–$26M
Jan Hruska
Angel
2 United Kingdom Seed, Venture - Series Unknown Medical, Health Care, Life Science
Charlie Songhurst
Angel
2 United Kingdom, United States, Germany Seed, Pre-Seed Software, Information Technology, Artificial Intelligence $500k–$8M
Paul Forster
Angel
2 United Kingdom, Germany, United States Seed, Series A, Pre-Seed Software, FinTech, Financial Services $1M–$26M
Tim Davis
Angel
2 United States, United Kingdom, Germany Series A, Series B, Seed Health Care, Medical, Biotechnology
Darrin Disley
Angel
2 United Kingdom Seed, Series A Biotechnology, Health Care, Big Data $462k–$3.7M
Nadav Ben-Chanoch
Angel
2 United States, France, United Kingdom Seed, Pre-Seed, Series A Software, Information Technology, Artificial Intelligence $120k–$30M
Bernard Majoie
Angel
2 France, Belgium Seed, Pre-Seed, Series A Biotechnology, Medical, Health Care $1.4M–$2.7M
Damien Lane
Angel
2 United Kingdom, United States, Ireland Seed, Pre-Seed, Series A Software, SaaS, Health Care $459k–$16M
Bertrand Jacquelot
Angel
2 France, United States Pre-Seed, Seed, Angel Food and Beverage, E-Commerce, Information Technology $120k–$7.8M
Ed Parkinson
Angel
2 United Kingdom Seed Health Care, Life Science, Biotechnology $1.9M–$3M
Thor Bjorgolfsson
Angel
2 United Kingdom, Germany Seed, Series A, Series C Big Data, TV, B2B $26M–$26M
Aidan Gomez
Angel
2 United States, United Kingdom, Canada Seed, Pre-Seed, Series A Artificial Intelligence, Software, Information Technology $1.8M–$12M
Annemie Van de Casteele
Angel
1 Belgium Seed Medical, Life Science, Biotechnology
Michelle Tempest
Angel
1 United Kingdom Seed, Series A Health Care, Cannabis, Life Science
Keith Willey
Angel
1 United Kingdom, Spain, Portugal Seed, Angel, Pre-Seed Software, Gaming, Real Estate $446k–$6.5M
Mikael Lonn
Angel
1 Sweden Series A Medical, Life Science, Biotechnology
David Lucas
Angel
1 United Kingdom Seed Software, Life Science, Biotechnology
Sami Mikati
Angel
1 India, United Kingdom Seed Biotechnology, Software, Life Science
Access all 50 angel investors in Europe Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 11 investments in Europe Life Science startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 63
  • Round size: Seed $537k–$25M; Series A $4.5M–$50M; Series B $1.6M–$56M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
  • Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 5 investments in Europe Life Science startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Israel

Investor stats

  • Total investments: 16
  • Round size: Seed $1.1M–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$21M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Teora — Crude oil derived products have infiltrated every industry – synthetic colors, flavors, fragrances in food, dyes in textiles, fertilizers and packaging material that harm humans and the planet. TeOra’s mission is to replace synthetics with naturals that are manufactured in a sustainable and predictable manner. A microorganism is the best factory,optimized over billions of years of evolution and TeOra designs it to produce desired products. Using microfluidics and AI, TeOra offers 100 times faster and cheaper design of smart micro-organisms in weeks to months instead of years.
  • thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
  • Lindus Therapeutics — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 3 investments in Europe Life Science startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Blockchain, Software, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Italy, United Kingdom, Canada

Investor stats

  • Total investments: 18
  • Round size: Seed $100k–$18M; Pre-Seed $874k–$2.2M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Freatic — Building the monetization layer for your alpha
  • Niulinx — Niulinx specializes in providing autonomous driving technology solutions based on artificial intelligence, connectivity, and data analytics.
  • Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.
Show all investments...

Jeff Dean
Angel · Palo Alto, California, United States · 3 investments in Europe Life Science startups

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Japan

Investor stats

  • Total investments: 106
  • Round size: Seed $2.3M–$34M; Pre-Seed $450k–$2.3M; Series A $10M–$60M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Terraton — Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.
  • Moonlake AI — Vibe code games and worlds into existence.
  • Periodic Labs — From bits to atoms.
Show all investments...

Annie Vereecken
Angel · Antwerp, Antwerpen, Belgium · 3 investments in Europe Life Science startups

Annie Vereecken

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Hospital
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Belgium

Investor stats

  • Total investments: 7
  • Round size: Seed $2M–$6M; Series A $9.2M–$30M; Venture - Series Unknown $4.1M–$8.8M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
  • Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Andrew Keys
Angel · 3 investments in Europe Life Science startups

Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.

Show more...

Investment focus

  • Industry: Software, Finance, Blockchain
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Norway

Investor stats

  • Total investments: 14
  • Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Stackr Labs — Micro-rollups to scale web3 applications
  • Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
  • Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States · 3 investments in Europe Life Science startups

Jude Gomila is currently CEO and Founder of the startup Golden.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 67
  • Round size: Seed $1.4M–$5M; Angel $70k–$1.3M; Pre-Seed $1M–$2.9M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Clara — Clara is an AI-powered primary care doctor.
  • Dirac Labs — Universal Navigation Powered by Quantum Sensing & AI
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Show all investments...

David Helgason
Angel · Copenhagen, Hovedstaden, Denmark · 2 investments in Europe Life Science startups

David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.

Show more...

Investment focus

  • Industry: Software, Gaming, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Denmark, Finland

Investor stats

  • Total investments: 81
  • Round size: Seed $1M–$8.3M; Pre-Seed $242k–$2.4M; Series A $5.4M–$30M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • ScyAI — Risk intelligence that thinks with you.
  • Noah — API-first stablecoin payments, enterprise-grade compliance and real-time settlements, powered by stablecoin technology.
  • Flow Engineering — Requirements management, made collaborative
Show all investments...

Ian Hogarth
Angel · London, England, United Kingdom · 2 investments in Europe Life Science startups

Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 62
  • Round size: Seed $1.7M–$14M; Pre-Seed $698k–$7.5M; Series A $11M–$43M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
  • Cordless — Bridging the gap between voice and text
  • Fabric — Fabric is an AI-powered workspace and file manager for people and groups.Fabric is a self-organizing multiplayer workspace.
Show all investments...

Ersin Pamuksüzer
Angel · Bodrum, Mugla, Turkey · 2 investments in Europe Life Science startups

Ersin Pamuksüzer

Show more...

Investment focus

  • Industry: Education, Life Science, Virtual Reality
  • Stage:Seed, Series A
  • Geography: Turkey, Germany

Investor stats

  • Total investments: 5
  • Round size: Seed $300k–$500k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Aposto — All-in-one media service currently based in Istanbul, Turkey.
  • VRLab Academy — VRLab Academy | Virtual Experiments
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Mark Evans
Angel · London, England, United Kingdom · 2 investments in Europe Life Science startups

Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.

Show more...

Investment focus

  • Industry: Retail, Fashion, Software
  • Stage:Series A, Seed, Series C
  • Geography: United Kingdom, United States, The Netherlands

Investor stats

  • Total investments: 37
  • Round size: Seed $1.4M–$8M; Series A $3.2M–$24M; Series C $8M–$68M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • ONI — Where are you in your super-resolution journey? ONI is here to support you along your super-resolution journey Answer a few simple questions to discover key resources that can help you make the most of single-molecule imaging technology across a wide range of applications Products Gallery FAQs Subscribe to our mailing list
  • Ufonia — Dora is a clinical AI agent that calls and supports your cataract patients, empowering your ophthalmology practice to scale without compromise on care.
  • Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Show all investments...

Sauli Törmälä
Angel · Helsinki, Southern Finland, Finland · 2 investments in Europe Life Science startups

Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Seed
  • Geography: Finland

Investor stats

  • Total investments: 2
  • Round size: Seed $598k–$1.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Show all investments...

Sylvain Zimmer
Angel · Paris, Ile-de-France, France · 2 investments in Europe Life Science startups

Sylvain Zimmer is based out of Paris, Ile-de-France and is the Chief Technology Officer of La Suite territoriale (EIG) of Direction interministérielle du numérique. Sylvain previously worked at Contentsquare as a head of the CTO office. Sylvain Zimmer attended the National School of Computer Science and Applied Mathematics of Grenoble.

Show more...

Investment focus

  • Industry: Software, SaaS, Real Estate
  • Stage:Seed, Pre-Seed, Angel
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 26
  • Round size: Seed $740k–$10M; Angel $400k–$500k; Pre-Seed $200k–$2.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
  • Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
  • TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Show all investments...

Andrew Nutter
Angel · Paris, Ile-de-France, France · 2 investments in Europe Life Science startups

Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.

Show more...

Investment focus

  • Industry: Software, SaaS, FinTech
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: France, United Kingdom, United States

Investor stats

  • Total investments: 25
  • Round size: Seed $550k–$4.9M; Pre-Seed $902k–$3.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Yavin — Yavin provides modern point-of-sale solutions for European merchants. Yavin is a tool to receive payments, sell smarter, and grow the business.
  • Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
  • EV Biotech — DANU strain engineering creates Precision Biopolymers For High-Performance Applications through strain engineering and AI.
Show all investments...

Paul Wicks
Angel · London, England, United Kingdom · 2 investments in Europe Life Science startups

Paul Wicks, Ph.D., is a strategic advisor and independent consultant who helps digital health and life science companies turn data into evidence, evidence into influence, and influence into impact. He has supported over 40 organizations including AstraZeneca, Ada Health, Biogen, Click Therapeutics, and Woebot.Previously, Paul spent 13 years as VPof R&D at PatientsLikeMe, building one of the world’s largest patient communities and pioneering decentralized trials, digital biomarkers, and real-world evidence. He has authored over 200 peer-reviewed papers and served on editorial boards of journals including the BMJ, Digital Biomarkers, and BMC Medicine.A neuropsychologist by training, Paul completed his Ph.D. at King’s College London and a postdoc on the psychology of Parkinson’s disease. His work has been featured by BBC, CNN, and The New York Times. He was named MIT Technology Review’s “Humanitarian of the Year” in 2011 and is a TED Fellow and FLIER alumnus of the Academy of Medical Sciences. He is an honorary Professor at the University of Birmingham.

Show more...

Investment focus

  • Industry: Software, Wellness, E-Commerce
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Japan

Investor stats

  • Total investments: 17
  • Round size: Seed $3M–$6.6M; Pre-Seed $539k–$1M; Series A $6.7M–$11M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Stelia — Stelia builds distributed AI platforms that scale globally. Research-driven intelligent systems for healthcare, education, and enterprise operations worldwide
  • Epiminds — Epiminds develops multi-agent AI systems to run marketing end-to-end.
  • Scooch — All-in-one subscription to eliminate hassle from your pet healthcare. From online assessment, health tracking and AI assistant to 24/7 vet support and vet-formulated treatments.
Show all investments...

Dr Guntard Gutmann
Angel · 2 investments in Europe Life Science startups

Dr Guntard Gutmann

Show more...

Investment focus

  • Industry: Health Care, Life Science, Therapeutics
  • Stage:Convertible Note, Venture - Series Unknown
  • Geography: Germany

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • HMNC Brain Health — HMNC Brain Health develops patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders.Founded in 2010, the privately held biotech company combines the development of machine learning-enabled companion diagnostics with specifictherapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. The ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. HMNC Brain Health strives to reduce not only the immense individual burden but also the societal impact of these diseases.
Show all investments...

Albert Wenger
Angel · New York, New York, United States · 2 investments in Europe Life Science startups

Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.

Show more...

Investment focus

  • Industry: Software, Internet, Analytics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 110
  • Round size: Seed $650k–$16M; Series A $1M–$23M; Series B $4.3M–$30M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Brale — One regulated system for stablecoin issuance, custody, payments, and compliance. 75+ programs in production across 45 US jurisdictions. SOC 2 Type II. Book a demo.
  • Terra.do — Learn about climate change and start working on climate change solutions today with the Terra.do community.
  • Phlair — 77NEKO menjadi salah satu akses asli untuk bermain game online yang menghasilkan sulthan dengan secara sekejap. Bukan hanya itu tapi 77neko sering memberikan bonus yang gokil seperti petir merah yang tak terhingga, cashback 100% hingga spin gratis di setiap permainan.
Show all investments...

Nicholas Edwards
Angel · Oxford, Oxfordshire, United Kingdom · 2 investments in Europe Life Science startups

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed, Venture - Series Unknown
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

Leena Niemistö
Angel · Helsinki, Southern Finland, Finland · 2 investments in Europe Life Science startups

Leena Niemistö

Show more...

Investment focus

  • Industry: Health Care, Software, E-Commerce
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Finland, United States

Investor stats

  • Total investments: 19
  • Round size: Seed $306k–$3.2M; Venture - Series Unknown $2.2M–$3.5M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Rens Original — RENS Original is the World's First Sneaker made from recycled coffee and plastic. We know you've been drinking it, now it is time to wear it.
  • Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Show all investments...

Nico Wittenborn
Angel · New York, New York, United States · 2 investments in Europe Life Science startups

Nico Wittenborn is an Investor at Adjacent.

Show more...

Investment focus

  • Industry: Software, Apps, Wellness
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, France

Investor stats

  • Total investments: 47
  • Round size: Seed $1.6M–$8.5M; Series A $6.9M–$40M; Series B $7.5M–$88M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • Mirage — Say hello to Captions, the only camera and editing app that automatically transcribes, captions and clips your talking videos for you.
  • Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
  • Momentum — Finally, a real solution for major gift fundraising. Powered by AI.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Matt Clifford
Angel · London, England, United Kingdom · 2 investments in Europe Life Science startups

Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States, India

Investor stats

  • Total investments: 41
  • Round size: Seed $756k–$7M; Pre-Seed $55k–$4.2M; Venture - Series Unknown $2.4M–$34M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Stackfix — Stackfix operates as a software comparison platform.
  • Rivan Industries — Rivan Industries designs and builds modular, vertically integrated, synthetic fuel plants.
  • Asymmetric Security — Asymmetric Security is an AI-native cybersecurity startup specializing in digital forensics and incident response. It combines elite forensic experts with proprietary AI to accelerate investigations, especially Business Email Compromise (BEC) attacks, at less than half the cost of competitors while shrinking timelines from days to hours.
Show all investments...

Carsten Maschmeyer
Angel · Hanover, Niedersachsen, Germany · 2 investments in Europe Life Science startups

Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Angel, Series A
  • Geography: Germany, Austria, Switzerland

Investor stats

  • Total investments: 83
  • Round size: Seed $116k–$4.2M; Angel $89k–$548k; Series A $1.6M–$24M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Zeedz — Gaming for a green future. Zeedz is a monster collectible game that targets real-world climate change. Discover a world of plantified magic, made in Berlin.
  • Finperks — finperks is a prepaid infrastructure API for banks, neobanks, HR platforms, etc. in Europe. Access 1000+ brands across 30+ countries. Simplify contracts, settlements, and integrations to scale your prepaid, cashback, and employee benefits solutions.
  • admark.ai — admark.ai combines cutting-edge AI language models with social media data
Show all investments...

Balaji Srinivasan
Angel · San Francisco Bay Area, California, United States · 2 investments in Europe Life Science startups, 17 in the past 12 months

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Singapore

Investor stats

  • Total investments: 275
  • Round size: Seed $2.3M–$15M; Pre-Seed $650k–$4.2M; Series A $6M–$28M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Vorflux — Cloud agents that ship production code. An opinionated harness that runs the full SDLC on dedicated machines.
  • Warp — Warp is a payroll and compliance tool that makes it easy for founders to hire, onboard, and pay their employees.
  • Dirac Labs — Universal Navigation Powered by Quantum Sensing & AI
Show all investments...

Michael Novogratz
Angel · New York, New York, United States · 2 investments in Europe Life Science startups

Michael E. Novogratz is based out of New York, New York, and is the Founder and CEO of Galaxy Digital. Michael previously served at Partner and President of Fortress Investment Group. Michael E. Novogratz attended Princeton University.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, FinTech
  • Stage:Seed, Series A, Series B
  • Geography: United States, India, Germany

Investor stats

  • Total investments: 34
  • Round size: Seed $1.1M–$8M; Series A $11M–$38M; Series B $15M–$150M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Curative — Get on-the-go COVID-19 testing and other essential health services, wherever you are.
  • Verandah — Verandah is story based conscious luxury resort brand retailing amongst the top 100 in the global luxury resort wear space with design roots strongly based in India. Verandah also has a line of 100% Italian made sustainable swimwear to compliment the season-less ready to wear line.
  • Mansa — Built by Black creators with a passion for making culture-positive content, Mansa is the only place to stream the best in Global Black stories
Show all investments...

Holger Hübner
Angel · Hamburg, Hamburg, Germany · 2 investments in Europe Life Science startups

Holger Hübner

Show more...

Investment focus

  • Industry: B2B, SaaS, Audio
  • Stage:Seed, Pre-Seed
  • Geography: Germany

Investor stats

  • Total investments: 5
  • Round size: Seed $560k–$1.1M; Pre-Seed $177k–$342k
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • musicube — MassiveMusic is a global music and sound partner specializing in sonic branding, sound strategy, music innovation & licensing.
  • RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
  • HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
Show all investments...

Robert Kopple
Angel · Los Angeles, California, United States · 2 investments in Europe Life Science startups

Robert C. Kopple is based out of Vancouver, Ontario, and is the Partner of Kopple, Klinger & Elbaz. Robert previously worked at Gelum Resources as a Board of Directors. Robert C. Kopple attended New York University.

Show more...

Investment focus

  • Industry: FinTech, Finance, Life Science
  • Stage:Convertible Note, Venture - Series Unknown
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 3
  • Round size: Venture - Series Unknown $3.3M–$4.8M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
  • ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Show all investments...

Mati Staniszewski
Angel · London, England, United Kingdom · 2 investments in Europe Life Science startups, 15 in the past 12 months

Mati Staniszewski is the Co-Founder of ElevenLabs.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Poland

Investor stats

  • Total investments: 22
  • Round size: Seed $4.5M–$11M; Pre-Seed $2M–$20M; Series A $16M–$75M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • imagi — Programming has never been this much fun! Learn to create with code, share your designs with friends on the imagiLabs app and customize your imagiCharm - a fun, easy-to-use, colorful, and educational toy for girls. Imagine it. Code it. Wear it.
  • Dwelly — Dwelly acquires and partners with independent UK lettings agencies, helping owners exit smoothly, profitably and on their terms. Get a free agency valuation.
  • Arrakis Security — Secure the enterprise agents where they're deployed. Total visibility, governance, and remediation for the autonomous workforce.
Show all investments...

Simon Galbraith
Angel · Cambridge, Cambridgeshire, United Kingdom · 2 investments in Europe Life Science startups

Simon is the joint founder and CEO of Redgate Software. Over the past 15 years, Simon has been part of Redgate’s growth from a 2 person firm operating out of a spare room to today’s 300 person outfit with hundreds of thousands of users. Although Simon’s responsibilities are primarily strategic, his background is technical with qualificationsincluding a PhD in physics from Cambridge University and former employment with Shell and ThornEMI.

Show more...

Investment focus

  • Industry: Software, Health Care, Life Science
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: Croatia, United Kingdom

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • BoobyBiome — BoobyBiome harnesses breast milk microbiome science to develop products to improve infant health
  • Syskit — Syskit Point keeps your Microsoft 365 environment under control - secured, cost-optimized, and AI confident.
Show all investments...

Luc Vauterin
Angel · Ghent, Oost-Vlaanderen, Belgium · 2 investments in Europe Life Science startups

Luc Vauterin - Board Member @ ONTOFORCE

Show more...

Investment focus

  • Industry: Software, Analytics, Life Science
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • ONTOFORCE — ONTOFORCE helps life sciences organizations accelerate research and drug development for improved patient outcomes by unlocking hidden insights from data. Founded on semantic technology and an ontology-based knowledge graph, their flagship product, DISQOVER, is a data and knowledge platform developed specifically for the life sciences industry.DISQOVER seamlessly connects an organization’s internal, siloed data with licensed data and public data in one easy-to-use, customizable platform, enabling efficient data exploration and analysis. DISQOVER has over 10,000 users across the globe and is deployed by many leading pharmaceutical and biotechnology companies. Users include scientific researchers, bioinformaticians, data scientists, and many other roles. ONTOFORCE is headquartered in Ghent, Belgium and has a secondary office in the United States in Cambridge, Massachusetts. Learn more about ONTOFORCE at ontoforce.com and try DISQOVER at disqover.com.
Show all investments...

Bradley Horowitz
Angel · Palo Alto, California, United States · 2 investments in Europe Life Science startups

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 135
  • Round size: Seed $150k–$18M; Series A $7.5M–$36M; Series B $19M–$120M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Key AI — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
  • Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
  • Odyssey — Odyssey is an AI lab pioneering general world models: causal, multimodal systems that learn to understand and simulate the world.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Edward Lando
Angel · San Francisco, California, United States · 2 investments in Europe Life Science startups

Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.

Show more...

Investment focus

  • Industry: Software, FinTech, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 575
  • Round size: Seed $950k–$6.3M; Pre-Seed $125k–$3.3M; Series A $5.5M–$37M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Humera — Humera - AI CAPTCHA That Knows You're Human
  • Allonic — Allonic is a robotics hardware company pioneering 3D Tissue Braiding, a new manufacturing platform for producing integrated, compliant, bio-inspired robotic bodies through a single, fully automated production process. By eliminating assembly-heavy designs and supply-chain complexity, Allonic enables significantly faster iteration, lower costs, andsafer, more dexterous robots to be built. Originally founded from Hungary and operating internationally with a US HQ and a growing team of 15, Allonic is building the hardware foundation for the next generation of intelligent machines.
  • Heywa Labs — Two products, one engine. Heywa Studio for businesses, Heywa for anyone with a question worth following.
Show all investments...

Pierre Drion
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in Europe Life Science startups

Pierre Drion - CEO @ Petercam

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B
  • Geography: Belgium

Investor stats

  • Total investments: 5
  • Round size: Series A $8.8M–$14M; Series B $18M–$26M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
  • Santero Therapeutics — This is the homepage of the website
Show all investments...

Jan Hruska
Angel · Abingdon, Oxfordshire, United Kingdom · 2 investments in Europe Life Science startups

Jan Hruska

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed, Venture - Series Unknown
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

Charlie Songhurst
Angel · Greater Seattle Area, Washington, United States · 2 investments in Europe Life Science startups, 25 in the past 12 months

Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 251
  • Round size: Seed $1.1M–$8M; Pre-Seed $500k–$5.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Zaro — Your context, your governance, your data with apps and agents on top. Owned by you, live in hours.
  • Uncovr — Surgical video is the biggest dark data in medicine. We turn it into operative reports, billing codes, and clinical intelligence automatically
  • Structured AI — Construction AI QA/QC software that automatically reviews drawing packages and catches errors, code issues, and coordination clashes before they reach the field.
Show all investments...

Paul Forster
Angel · Cambridge, Massachusetts, United States · 2 investments in Europe Life Science startups

Paul Forster is an early-stage investor in the tech sector. He previously worked at Indeed as a Senior Advisor. Paul attended INSEAD, where he earned an MBA.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 81
  • Round size: Seed $1M–$6.9M; Pre-Seed $1.1M–$3.5M; Series A $3.7M–$26M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Oraion — Your single source of truth for enterprise data
  • Wassist — Launch your AI sales agent on WhatsApp for Shopify in under 60 seconds. Recover 30-50% of abandoned carts and increase conversions by 3x.
  • Capsa AI — Providing next-generation investors with a competitive edge.
Show all investments...

Tim Davis
Angel · Santa Monica, California, United States · 2 investments in Europe Life Science startups

Timothy T Davis, MD is Board Certified in Physical Medicine and Rehabilitation (Physiatry) and Pain Medicine. The founder of Source Healthcare, Source Surgery Center, Alpha Diagnostics and he is an expert in spine and musculoskeletal disorders as well as interventional pain management to treat neck, back and sports injuries. Dr. Davis hasperformed extensive clinical research using biological therapies such as stem cells and other biologics for spine and joint injuries. He has consulted and invested in SaaS, medical device, biologics, cannabis, and psychedelics sectors.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 10
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bryn Pharma — Bryn Pharma is a pharmaceutical company that offers nasal-based epinephrine for anaphylaxis. Its bi-dose intranasal device is an alternative to epinephrine auto-injectors and is needle-free. It is easy to use and portable enabling patients to treat allergic reactions or anaphylactic reactions.
  • Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
  • MycoMedica Life Sciences, PBC — Psychedelic Medicines
Show all investments...

Darrin Disley
Angel · Cambridge, Cambridgeshire, United Kingdom · 2 investments in Europe Life Science startups

Darrin Disley is based out of Cambridge, Cambridgeshire, and is the Executive Chairman and Director of Cardiogeni. Darrin previously worked at Mogrify as Chief Executive Officer, Director, and Investor. Darrin Disley attended the University of Cambridge.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Big Data
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 5
  • Round size: Seed $462k–$3.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • bit.bio — Bit.bio provides engineered human cell products and platform services for biomedical research, drug discovery, and cell therapy development. The company uses a precision cell programming system to convert stem cells into defined human cell types and supplies a portfolio of reprogrammed cells, custom cell development services, and research-readyhuman cell models for scientific and pharmaceutical use. Bit.bio also supports integration of its products into partner research ecosystems and offers platform capabilities that help identify transcription factors for specific cell states. Its focus includes enabling scalable access to human cell models for experiments, screening workflows, and therapeutic investigation.
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Show all investments...

Nadav Ben-Chanoch
Angel · Miami, Florida, United States · 2 investments in Europe Life Science startups

Nadav Ben-Chanoch

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 232
  • Round size: Seed $500k–$6M; Pre-Seed $120k–$2.5M; Series A $4M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Swaap — We build & operate onchain trading systems. We are a group of scientists and technologists committed to build open systems.
  • micro1 — We help companies hire and manage the best software engineers easily.
  • Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
Show all investments...

Bernard Majoie
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in Europe Life Science startups

Bernard Majoie - President @ Fournier-Majoie

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, Belgium

Investor stats

  • Total investments: 6
  • Round size: Seed $1.4M–$2.7M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • reMYND — Driving the development of disease-modifying treatments
  • AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
  • PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Show all investments...

Damien Lane
Angel · London, England, United Kingdom · 2 investments in Europe Life Science startups

Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 39
  • Round size: Seed $459k–$3.1M; Pre-Seed $660k–$1M; Series A $3.2M–$16M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Narchie — Create a home that's uniquely yours with Narchie. Shop sustainably, minimize waste, and find one-of-a-kind homeware items.
  • Surgery Hero — We combine expert human care, individually-tailored content and cutting edge tech to empower people to take control of their health so they can conquer their surgery.
  • Surgery Hero — We combine expert human care, individually-tailored content and cutting edge tech to empower people to take control of their health so they can conquer their surgery.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Bertrand Jacquelot
Angel · Paris, Ile-de-France, France · 2 investments in Europe Life Science startups

Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.

Show more...

Investment focus

  • Industry: Food and Beverage, E-Commerce, Information Technology
  • Stage:Pre-Seed, Seed, Angel
  • Geography: France, United States

Investor stats

  • Total investments: 20
  • Round size: Seed $1.5M–$7.8M; Pre-Seed $120k–$1.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
  • Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
  • Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
Show all investments...

Ed Parkinson
Angel · 2 investments in Europe Life Science startups

Ed Parkinson

Show more...

Investment focus

  • Industry: Health Care, Life Science, Biotechnology
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Round size: Seed $1.9M–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Antiverse — Designing biologics for 100 challenging targets
Show all investments...

Thor Bjorgolfsson
Angel · London, England, United Kingdom · 2 investments in Europe Life Science startups

Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.

Show more...

Investment focus

  • Industry: Big Data, TV, B2B
  • Stage:Seed, Series A, Series C
  • Geography: United Kingdom, Germany

Investor stats

  • Total investments: 6
  • Round size: Series A $26M–$26M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Olvin — Menara188 ialah situs yang di jamin amanah dengan layanan super aman di jamin terpercaya resmi , ewallet digital hanya depo 5k sudah bisa bermain disini.
  • DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
  • AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
Show all investments...

Aidan Gomez
Angel · Oxford, Arkansas, United States · 2 investments in Europe Life Science startups

Aidan Gomez is based out of Toronto, Ontario and is the co-founder & CEO at Cohere. Aidan Gomez attended the University of Oxford.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 17
  • Round size: Seed $2.8M–$12M; Pre-Seed $1.8M–$3.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • DatologyAI — DatologyAI optimize training efficiency, maximize performance and reduce compute costs with expert curation.
  • Extropic AI — The next era of computing isn't dead. It's alive. More coming soon.
  • Helical — The full power of DNA & (m)RNA Bio Foundation Models in one open-core platform. Accelerate Drug Discovery with AI.
Show all investments...

Annemie Van de Casteele
Angel · 1 investments in Europe Life Science startups

Annemie Van de Casteele is a former member of the Belgian Parliament.

Show more...

Investment focus

  • Industry: Medical, Life Science, Biotechnology
  • Stage:Seed
  • Geography: Belgium

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • 4Tissue — Shaping the Future of Regenerative Medicine
Show all investments...

Michelle Tempest
Angel · 1 investments in Europe Life Science startups

Michelle Tempest

Show more...

Investment focus

  • Industry: Health Care, Cannabis, Life Science
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Daye — Daye has set out to build a new brand for female health products “designed with women in mind.” The startup’s first product is a newly developed tampon that uses CBD to help tackle period cramps (or dysmenorrhea) as an alternative to traditional painkillers (CBD is the extract derived from the flower of the industrial hemp plant, a legal relativeto marijuana).
  • Medwise.ai — Medwise.ai is the Google for doctors.
Show all investments...

Keith Willey
Angel · London, England, United Kingdom · 1 investments in Europe Life Science startups

Keith is an associate professor of strategic and international management and entrepreneurship at London Business School as well as a senior lecturer at University College London. He also holds various non-executive directorships and advisory roles. His career has spanned academia, consulting, investing and hands-on operational roles withinindustry and the venture capital world.

Show more...

Investment focus

  • Industry: Software, Gaming, Real Estate
  • Stage:Seed, Angel, Pre-Seed
  • Geography: United Kingdom, Spain, Portugal

Investor stats

  • Total investments: 9
  • Round size: Seed $1.4M–$6.5M; Angel $446k–$1.3M; Pre-Seed $721k–$2.2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
  • Connected — Connected is a startup that offers affordable connecting humans, unleashing a new wave of IoT-based business models and contributing to bridge the digital gap.
  • Sensible Object — Sensible Object Makes games that combine beautiful things, custom hardware and digital apps into new kinds of play.
Show all investments...

Mikael Lonn
Angel · 1 investments in Europe Life Science startups

Mikael Lonn is an Angel Investor.

Show more...

Investment focus

  • Industry: Medical, Life Science, Biotechnology
  • Stage:Series A
  • Geography: Sweden

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Show all investments...

David Lucas
Angel · 1 investments in Europe Life Science startups

David Lucas

Show more...

Investment focus

  • Industry: Software, Life Science, Biotechnology
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Show all investments...

Sami Mikati
Angel · 1 investments in Europe Life Science startups

Sami Mikati is a Director of Synthace Ltd. Investor and commercial executive with deep experience and network across energy and engineering industries in Europe, the Middle East and Africa.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Life Science
  • Stage:Seed
  • Geography: India, United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Angel Investors in Europe investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 angel investors investing in Europe Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists